Total planned funding: $156,244,592
Allocations
Countries/Regions
India | $156,244,592 |
Organizational Types
NGO | $58,743,205 |
Unknown | $38,784,736 |
Own Agency | $28,918,767 |
University | $16,282,112 |
Private Contractor | $3,339,272 |
Multi-lateral Agency | $3,310,000 |
Implementing Agency | $3,100,000 |
FBO | $1,600,000 |
Host Country Government Agency | $1,539,200 |
Other USG Agency | $627,300 |
Program Areas
Governance and Systems | $70,767,512 |
Prevention | $34,168,817 |
Management and Operations | $20,425,129 |
Care | $16,859,443 |
Treatment | $7,600,481 |
Testing | $6,423,210 |
Budget Codes
OHSS: Health Systems Strengthening | $41,180,298 |
HVSI: Strategic Information | $24,082,973 |
HVMS: Management and Operations | $20,425,129 |
HVOP: Sexual Prevention: Other Sexual Prevention | $19,808,374 |
HBHC: Care: Adult Care and Support | $8,314,911 |
HTXS: Treatment: Adult Treatment | $7,046,986 |
HVCT: Testing: HIV Testing and Counseling | $6,423,210 |
HLAB: Laboratory Infrastructure | $5,504,241 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $5,375,472 |
HKID: Care: Orphans and Vulnerable Children | $4,226,162 |
HVTB: Care: TB/HIV | $3,495,030 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $3,112,090 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $3,089,202 |
HMBL: Biomedical Prevention: Blood Safety | $2,773,679 |
PDCS: Care: Pediatric Care and Support | $823,340 |
PDTX: Treatment: Pediatric Treatment | $530,018 |
HTXD: Treatment: ARV Drugs | $23,477 |
HMIN: Biomedical Prevention: Injection Safety | $10,000 |
Top Partner Programs
Not Available:
$38,160,247
Countries/Regions
FHI 360:
$19,251,882
Countries/Regions
USG Aggregated Agencies:
$15,776,285
Countries/Regions
Voluntary Health Services:
$11,460,000
Countries/Regions